The mechanism responsible for the angina symptoms in these patients is not completely understood, but endothelin-1 is thought to have a key role considering that patients have increased endothelin levels; the angiographic phenomenon is produced by intracoronary endothelin administration in animal models, and an endothelin blocker has been shown to have anti-anginal benefits [23]. This evidence concerns the gene EDN1 and angina pectoris.